It is generally accepted that atherosclerosis is the extreme manifestation
of what begins as a protective, fibroproliferative response to injury. Athe
rosclerosis can become pathological as a result of chronic, excessive expos
ure to particular causative agents. Several pathophysiological systems, inc
luding the inflammatory response, the immune response, cellular growth and
proliferation, lipoprotein metabolism and coagulation, each of which operat
es as the result of the contributions of numerous gene products, can contri
bute to atherosclerosis either individually or in concert. In theory, ident
ifying the genetic component(s) of atherosclerosis has become possible with
molecular technologies and analytical methods. Reductionist experimental m
odels have produced a list of several hundred candidate genes for the study
of the genetic component of atherosclerosis. Within some families and isol
ated communities, the effect of a single gene upon atherosclerosis suscepti
bility may be profound, such as in the case of mutations within the gene en
coding the low density lipoprotein receptor. However, at the level of the g
eneral population, particular candidate genes have small effects on atheros
clerosis, or on one of its intermediate phenotypes. Furthermore, there are
other factors, such as pleiotropy, epistasis, variations in genetic backgro
und, differences in individual environmental landscape, non-linear interact
ions among gene products and interactions between genes and the environment
, which can confound the study of the genetic component of atherosclerosis.
(C) 1999 Elsevier Science Ireland Ltd. All rights reserved.